Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.

Autor: Bostrom MA; Wake Forest School of Medicine, Winston-Salem, NC, USA., Kao WH, Li M, Abboud HE, Adler SG, Iyengar SK, Kimmel PL, Hanson RL, Nicholas SB, Rasooly RS, Sedor JR, Coresh J, Kohn OF, Leehey DJ, Thornley-Brown D, Bottinger EP, Lipkowitz MS, Meoni LA, Klag MJ, Lu L, Hicks PJ, Langefeld CD, Parekh RS, Bowden DW, Freedman BI
Jazyk: angličtina
Zdroj: American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2012 Feb; Vol. 59 (2), pp. 210-21. Date of Electronic Publication: 2011 Nov 25.
DOI: 10.1053/j.ajkd.2011.09.020
Abstrakt: Background: African Americans have increased susceptibility to nondiabetic nephropathy relative to European Americans.
Study Design: Follow-up of a pooled genome-wide association study (GWAS) in African American dialysis patients with nondiabetic nephropathy; novel gene-gene interaction analyses.
Setting & Participants: Wake Forest sample: 962 African American nondiabetic nephropathy cases, 931 non-nephropathy controls. Replication sample: 668 Family Investigation of Nephropathy and Diabetes (FIND) African American nondiabetic nephropathy cases, 804 non-nephropathy controls.
Predictors: Individual genotyping of top 1,420 pooled GWAS-associated single-nucleotide polymorphisms (SNPs) and 54 SNPs in 6 nephropathy susceptibility genes.
Outcomes: APOL1 genetic association and additional candidate susceptibility loci interacting with or independently from APOL1.
Results: The strongest GWAS associations included 2 noncoding APOL1 SNPs, rs2239785 (OR, 0.33; dominant; P = 5.9 × 10(-24)) and rs136148 (OR, 0.54; additive; P = 1.1 × 10(-7)) with replication in FIND (P = 5.0 × 10(-21) and 1.9 × 10(-05), respectively). rs2239785 remained associated significantly after controlling for the APOL1 G1 and G2 coding variants. Additional top hits included a CFH SNP (OR from meta-analysis in the 3,367 African American cases and controls, 0.81; additive; P = 6.8 × 10(-4)). The 1,420 SNPs were tested for interaction with APOL1 G1 and G2 variants. Several interactive SNPs were detected; the most significant was rs16854341 in the podocin gene (NPHS2; P = 0.0001).
Limitations: Nonpooled GWASs have not been performed in African American patients with nondiabetic nephropathy.
Conclusions: This follow-up of a pooled GWAS provides additional and independent evidence that APOL1 variants contribute to nondiabetic nephropathy in African Americans and identified additional associated and interactive nondiabetic nephropathy susceptibility genes.
(Copyright © 2012 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.)
Databáze: MEDLINE